Additionally, elevated expression of IFN-γ and IFN-γ-induced genes in pre-treatment tumors is associated with clinical response in patients with melanoma, although there was no such association reported in NSCLC or renal cell carcinoma [28]. This evidence concerns the gene IFNG and renal cell carcinoma.